[New positive inotropic drugs].
Lehot
J J
JJ
Département d'Anesthésie-Réanimation, Hôpital Cardiovasculaire et Pneumologique Louis-Pradel, Lyon.
D000322:Adrenergic Agonists / Q000494:pharmacology* / Q000627:therapeutic use; D000676:Amrinone / Q000494:pharmacology; D002316:Cardiotonic Agents / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D004298:Dopamine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D017335:Enoximone; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D020105:Milrinone; D009200:Myocardial Contraction / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D011724:Pyridazines / Q000494:pharmacology; D011728:Pyridones / Q000494:pharmacology; D012770:Shock, Cardiogenic / Q000188:drug therapy
D000322:Adrenergic Agonists; D002316:Cardiotonic Agents; D007093:Imidazoles; D010726:Phosphodiesterase Inhibitors; D011724:Pyridazines; D011728:Pyridones; C039686:piroximone; C041648:pimobendan; C046318:dopexamine; D017335:Enoximone; D020105:Milrinone; D000676:Amrinone; D004298:Dopamine
Nouveaux médicaments inotropes positifs.